The Centers for Disease Control and Prevention (CDC) has updated guidance for people who travel to or live in the previously identified area of South Miami Beach, Fla. This area is no longer considered to be an area of active Zika virus transmission (red area). It is now designated as a Zika cautionary area (yellow area). There have been no new cases of local Zika virus transmission identified in South Miami Beach for more than 45 days, suggesting that the risk of Zika virus infection is no longer greater than in the rest of Miami-Dade County. All of Miami-Dade County continues to have the yellow area designation and pregnant women are eligible for Zika virus testing.
All pregnant women in the United States should be evaluated for possible Zika virus exposure during each prenatal care visit. Each evaluation should include an assessment of signs and symptoms of Zika virus disease (fever, rash, joint pain, and red eyes), their travel history, and their sexual partner's potential exposure to Zika virus and history of any illness consistent with Zika virus disease. All pregnant women with possible exposure should be offered Zika virus testing.
“Florida’s rapid response and comprehensive mosquito control program has allowed them to interrupt Zika transmission, but we must stay vigilant and also take what we have learned and be prepared for next season,” said CDC director Tom Frieden, MD, MPH. “Pregnant women who live or have been to this area should continue to be evaluated for Zika exposure during their prenatal visits to prevent the devastating effects Zika can cause in their infants.”
As of Dec. 8, a total of 4,575 cases of Zika have been reported in the continental United States and Hawaii through CDC’s ArboNET. These cases include 185 locally transmitted mosquito-borne cases in Florida, 38 cases believed to be the result of sexual transmission, and one case that was the result of a laboratory exposure.
Source: CDC
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
IP LifeLine: Layoffs and the Evolving Job Market Landscape for Infection Preventionists
July 11th 2025Infection preventionists, once hailed as indispensable during the pandemic, now face a sobering reality: budget pressures, hiring freezes, and layoffs are reshaping the field, leaving many IPs worried about their future and questioning their value within health care organizations.